UPB
Upstream Bio, Inc.Company with tickers: UPB
CIK
2022626
CUSIP
91678A107
Shares Outstanding
54,419,986
Website
https://www.upstreambio.com
13F Activity (30d)
8 filings
3 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $1,034,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $44,649,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Research & Development | $36,565,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Operating Income | $-43,615,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-40,591,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $-0.75 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $-0.75 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |